GAP vs VRTX · P/E 9.9, rev $15.09B vs P/E 30, rev $12.00B
The Gap, Inc. (GAP) versus Vertex Pharmaceuticals Inc (VRTX) — a side-by-side from cached financials, not a winner call.
The Gap, Inc. (GAP) is a apparel retail company listed on US.
Vertex Pharmaceuticals Inc (VRTX) is a biotechnology company listed on US.
Latest reported GAP revenue for 2025-02-01 was $15.09B. Net income was $844.0M. Revenue was up 1.3% from 2024-02-03 to 2025-02-01. GAP currently screens at market cap $7.73B and trailing P/E 9.9.
Latest reported VRTX revenue for 2025-12-31 was $12.00B. Net income was $3.95B. Revenue was up 8.9% from 2024-12-31 to 2025-12-31. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
GAP currently screens at market cap $7.73B and trailing P/E 9.9. VRTX currently screens at market cap $106.87B and trailing P/E 29.7.
Not investment advice. Open the GAP and VRTX stock pages for the full models.
Not investment advice.